Avitptadil

Hyd-based Biophore seeks DCGI approval for use of Aviptadil in COVID treatment

Hyderabad: Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of…